- 學位論文
整合型微流體平台運用於檢測BRCA1基因突變及卵巢癌風險評估
An Integrated Microfluidic Platform for Detecting BRCA1 Gene Mutation and Risk Assessment of Ovarian Cancer
並列摘要
abstract hide
延伸閱讀
- 趙淑武、何師竹、洪耀欽、李玉華（1991）。合併CA-125及超音波以鑑別卵巢腫瘤之良惡性。The Kaohsiung Journal of Medical Sciences，7(8)，429-434。https://doi.org/10.6452/KJMS.199108.0429
- Yuan, L. K. (2018). 液態生物檢體應用在卵巢癌分類與篩檢 [master's thesis, National Chengchi University]. Airiti Library. https://doi.org/10.6814/THE.NCCU.CS.015.2018.B02
- Han, L. M., Lee, M. Y., Tsai, M. C., Chao, W. R., Han, C. P., & Wang, Y. T. (2015). 黏液性上皮卵巢癌第十七號染色體多套畸形對HER2狀態的影響：一項採取組織晶片及2010年全球胃癌第三期ToGA trial對小切片檢體評分基準的研究. 婦癌醫學期刊, (41), 14-23. https://www.airitilibrary.com/Article/Detail?DocID=P20150521002-201504-201505210033-201505210033-14-23
- Anirban, S. (2019). Integrated microfluidic systems for screening of affinity reagents and detection of molecular biomarkers [doctoral dissertation, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-0206202016171217
- Hsiung, L. C. (2010). A dielectrophoresis-based cellular microarray microfluidic system for anticancer drug screenings [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2010.01432